Respond to prefers-color-scheme dark in app web views

Follow section front redirects in Spectrum

Enable NLP source in PCS for load testing

Switch off the News Alerts Survey Widget when we have enough responses

Poll to determine if new LUF updates are available

Allows the winning A/B test variant to be turned on without Spectrum deployment

Show infinite scrolling sections in Assembler MultiView

Show option for NLP article summaries in Action Bar

Show NLP summaries collection recirc on article pages

A general feature flag for Recipe Features that aren't yet released

Feature flag for media team features that aren't yet released

Use new Orca video player for preroll plugin in Spectrum

Show the snow tracker (instead of the heat tracker) on Spectrum

Russia shows resilience. There is more to do for Ukraine.

Trump promises tax cuts and fewer rules. CEOs shouldn’t fall for it.

Tariffs against China hamstring the transition to a clean energy future

She finished chemo then got a medical degree: ‘The dream is real now’

Puppy abandoned with heart-rending note is adopted, named Minerva

Man, 91, shocks tiny firehouse with $500K gift: ‘Nobody knew how much I’d saved’

Joey Gallo returns, but Nats endure another quiet offensive night

Walter Johnson’s jersey from 1920 showdown with Babe Ruth sold at auction

Bryce Harper, Joey Gallo and a bond forged by baseball since they were kids

How Jim Jordan tried to connect the dots on Biden’s $8 million book deal

‘Never Trump?’ ‘Never Biden’ voters might loom larger.

Ukraine gamble pays off: Republicans face little backlash in primaries

The world’s coolest hotels want to tell you a story

Cruise ships to return to Baltimore two months after bridge collapse 

Some cruise prices are about to get a little more clear

Book Tour: At home with Amor Towles

In photos: The scene in Houston after severe storms killed at least 7 people

Deadly storm blasts Houston

Biden’s false claim that inflation was 9 percent when he took office

Did Obamacare ‘massively’ increase the cost of health care?

Carolyn Hax: Is it weird to ask other people to care about you?

Ask Amy: Can’t a single woman eat alone without interruption?

Miss Manners: Miss Manners: Gag gift falls flat

Blue Origin to fly again as space tourism struggles to get off the ground

Why this company’s biggest fans turned against it

Boeing delays spaceflight again as it continues to struggle with leak

Zelensky’s chief aide flexes power, irks critics — and makes no apologies

IDF recovers bodies of 3 Israelis killed on Oct. 7

With its energy network nearly destroyed, Ukraine already fears the winter

At campus protests, ‘DO NOT TALK TO THE MEDIA’!

CNN gets a presidential debate — and a much-needed win

Netflix will air NFL’s Christmas games, a major step for streaming service

Trump

Healthy living, including food, fitness, longevity and mental health

See more coverage in your recommendations

See alerts for Health and Wellness developments

Health & wellness

Tips on living better delivered every Thursday

Well+Being newsletter

Health alerts

Health & Science alerts

The Food and Drug Administration on Monday proposed a tougher enforcement policy toward homeopathic drugs, saying it would target products posing the greatest safety risks, including those containing potentially harmful ingredients or being marketed for cancer, heart disease and opioid and alcohol addictions.

Homeopathy is based on an 18th-century idea that substances that cause disease symptoms can, in very small doses, cure the same symptoms. Modern medicine, backed up by <a href="https://www.washingtonpost.com/news/morning-mix/wp/2015/03/11/no-evidence-homeopathy-is-any-better-than-a-placebo-major-australian-study-says/">numerous studies</a>, has disproved the central tenets of homeopathy and shown that the products are worthless at best and harmful at worst.

Under U.S. law, homeopathic drugs are required to meet the same approval rules as other drugs. But under a <a href="https://www.fda.gov/ICECI/ComplianceManuals/CompliancePolicyGuidanceManual/ucm074360.htm">policy</a> adopted in 1988, the agency has used “enforcement discretion” to allow the items to be manufactured and distributed without FDA approval. Agency officials don't plan to begin requiring that homeopathic products get approval — officials say that would be impractical —  but they are signaling stepped-up scrutiny for items deemed a possible health threat.

Examples of high-risk products include ones that are administered by injection, are intended for vulnerable populations like children or the elderly, or are marketed for serious diseases, the agency said.

The FDA's proposed approach, outlined in a <a href="https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM589373.pdf">draft guidance </a>that will be open for public for 90 days, comes more than a year after homeopathic teething tablets and gels containing belladonna were linked to 400 injuries and the deaths of 10 <a href="https://www.forbes.com/sites/brucelee/2017/01/28/fda-toxic-belladonna-in-homeopathic-teething-products/#193e5e3d40dd">children</a>. An FDA lab analysis later <a href="https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm538684.htm">confirmed</a> that some of the products “contained elevated and inconsistent levels of belladonna,” a toxic substance, the agency said.

Once a niche field, homeopathy has grown into to a $3 billion industry that peddles treatments for everything from cancer to colds, FDA Commissioner Scott Gottlieb noted in a statement. “In many cases, people may be placing their trust and money in therapies that may bring little or no benefit in combating serious ailments, or worse — that may cause significant and even irreparable harm” because of poor manufacturing quality or unsafe ingredients, he said.

Still, he said, the agency wants to balance its safety concerns with the desires of consumers who want to continue using the products.

Under its planned approach, many products won't be considered high risk and will remain available to consumers, Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, told reporters during a teleconference. But she said, the agency would “go after” products that cause — or might cause — “overt harm.”

The National Center for Homeopathy, which advocates for homeopathy and is based in Mount Laurel, N.J., says on its website that “homeopathy is a safe, gentle, and natural system of healing that works with your body to relieve symptoms, restore itself, and improve your overall health.”

Steven Salzberg, a biomedical engineer at Johns Hopkins University who in the past has <a href="https://www.forbes.com/sites/stevensalzberg/2016/11/21/ftc-steps-in-where-fda-fears-to-tread-homeopathy/#1d522cdd4175">criticized</a> the FDA for not taking action against homeopathy, said it was “terrific” that the agency now plans to try to rein in the industry. He cautioned that product makers are likely to “hit back hard with lots of spurious claims in an effort to confuse consumers and to protect their profits.”

Salzberg added that homeopathic products' packaging suggests that the items “cure all sorts of conditions — pain, colds, asthma, indigestion, arthritis, you name it — and yet there's not a whit of evidence” that they cure anything. The homeopathy field, he said, is “just silly from a scientific point of view, more like a religious belief than a scientific belief.”

In July, Britain's National Health System announced plans to stop doctors from prescribing homeopathic drugs. Simon Stevens, the system's chief executive, <a href="http://www.bbc.com/news/uk-40683915">described</a> homeopathy as “at best a placebo and a misuse of scarce NHS funds.” The move came years after the House of Commons <a href="https://publications.parliament.uk/pa/cm200910/cmselect/cmsctech/45/4507.htm">called</a> on the government health service to stop paying for homeopathic prescriptions, saying, “To maintain patient trust, choice and safety, the Government should not endorse the use of placebo treatments, including homeopathy.”

In April 2015, the FDA held public hearings on the way it regulates homeopathic products as part of an <a href="https://www.federalregister.gov/documents/2015/03/27/2015-07018/homeopathic-product-regulation-evaluating-the-food-and-drug-administrations-regulatory-framework">effort </a>to get public input on its enforcement polices. The agency said Monday that as a result of the hearing and 9,000 comments submitted by the public, the FDA had decided to propose a new “comprehensive, risk-based enforcement approach to drug products labeled as homeopathic and marketed without FDA approval.”

Over the past several years, the FDA has issued warnings about other homeopathic drug products, including zinc-containing intranasal <a href="https://wayback.archive-it.org/7993/20170113083935/http:/www.fda.gov/ForConsumers/ConsumerUpdates/ucm166931.htm">products</a> that may cause a loss of sense of smell; certain homeopathic <a href="https://wayback.archive-it.org/7993/20170112131529/http:/www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm439014.htm">asthma products</a> that have not been effective in treating asthma and other products that contain strychnine, a poison used to kill rodents.

<a href="https://www.washingtonpost.com/news/to-your-health/wp/2017/11/29/fda-paves-way-for-new-therapies-to-help-cigarette-smokers-quit/?utm_term=.678049d8702a">Quitting smoking is hard. The FDA wants new nicotine-replacement therapies to help.</a>

<a href="https://www.washingtonpost.com/news/to-your-health/wp/2017/11/14/fda-warns-of-deadly-risks-of-herb-kratom-citing-36-deaths/?utm_term=.bb4c9733f3e0">FDA warns about 'deadly risks' of the herb kratom, citing 36 deaths</a>

<a href="https://www.washingtonpost.com/news/to-your-health/wp/2017/10/25/fdas-gottlieb-calls-for-greater-use-of-medication-assisted-treatment-to-fight-opioid-epidemic/?utm_term=.cfdce8822199">FDA's Gottlieb calls for greater use of medication-assisted treatment to fight opioid epidemic</a>

Part of Wall Street Journal team that won the 1997 Pulitzer Prize for national reporting on AIDS 

Syracuse University, BS in journalism

Laurie McGinley covered health and medicine for The Washington Post, focusing on the Food and Drug Administration as well as cancer research and treatment. She was previously The Post's health, science and environment editor. 

Laurie McGinley

The Washington Post

Health Care

Medical Mysteries

Science

Well+Being

Health

prism://prism.query/site,/health&limit=20

The Washington Post health section provides coverage and analysis of health, healthcare, nutrition and fitness news.